COVID-19

Bharat Biotech starts trials for booster dose of Covaxin at AIIMS, Delhi and Patna

Covaxin manufacturer, Bharat Biotech today started trials for the booster dose of the vaccine at AIIMS, Delhi and Patna. It will be conducted in phase two clinical trial participants. The booster dose will be given to the participants after six months when they had received their second dose during the trial.  Last month, the Drug Controller General of India had given permission to Bharat Biotech to conduct clinical trials for a third booster dose of Covaxin. 

9 Comments

9 Comments

  1. Pingback: keto ingredients

  2. Pingback: free gay dating india

  3. Pingback: 1 mg tizanidine

  4. Pingback: latisse eyelash

  5. Pingback: clomid price canada

  6. Pingback: aralen tabs

  7. Pingback: 1privilege

  8. Pingback: http://www.sexyelders.eu/sexy-elders/?l=archive&pr=archive&u=https://rentcars.buzz/

Leave a Reply

Your email address will not be published.

16 − 6 =

News is information about current events. News is provided through many different media: word of mouth, printing, postal systems, broadcasting, electronic communication, and also on the testimony of observers and witnesses to events. It is also used as a platform to manufacture opinion for the population.

Contact Info

Address:
D 601  Riddhi Sidhi CHSL
Unnant Nagar Road 2
Kamaraj Nagar, Goreagaon West
Mumbai 400062 .

Email Id: [email protected]

West Bengal

Eastern Regional Office
Indsamachar Digital Media
Siddha Gibson 1,
Gibson Lane, 1st floor, R. No. 114,
Kolkata – 700069.
West Bengal.

Office Address

251 B-Wing,First Floor,
Orchard Corporate Park, Royal Palms,
Arey Road, Goreagon East,
Mumbai – 400065.

Download Our Mobile App

IndSamachar Android App IndSamachar IOS App
To Top
WhatsApp WhatsApp us